PUBLIC CONTRACT · 2026
Aquisição de estimulantes da eritropoiese, ao abrigo do AQ 2026/100, para a ULSASI, para o ano 2027
- Contract value
- €265,304.00
- Signed on
- 1 October 2026
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 15740191PUBLISHED SUBJECT
Aquisição de estimulantes da eritropoiese, ao abrigo do AQ 2026/100, para a ULSASI, para o ano 2027
Parties involved
- Place of performance
- Portugal, Lisboa, Amadora
- NUTS region
- PT1A0 - Grande Lisboa
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AMGEN BIOFARMACÊUTICA, LDA. · Tax ID 502942959
Values and timeline
- Contract price
- €265,304.00
- Procedure base price
- €266,175.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 8 October 2026
- Award date
- 30 September 2026
- Signing date
- 1 October 2026
- Performance period
- 364 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Acordo quadro de estimulantes da eritropoiese
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 11540793
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.